Recruiting now

Eczema trials recruiting right now

Registered Eczema studies that are open to new participants, by country.

Registered interventional studies recruiting for “Atopic dermatitis” anywhere

120

Showing 5 recent matches. Check the location and ages first, then open the record for full eligibility and contact details.

Recruiting nowPhase 120 planned
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Locations: Bethesda, Maryland
Ages: 12 Years to 120 Years1 sitestarted 2026National Institute of Allergy and Infectious Diseases (NIAID)
Check eligibility and contact details →
Recruiting nowPhase 3375 planned
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Locations: Northridge, California · Panama City, Florida · St. Petersburg, Florida
Ages: 12 Years3 sitesstarted 2026Pfizer
Check eligibility and contact details →
Recruiting nowNo phase stated40 planned
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Locations: New York, New York
Ages: 12 Years to 17 Years2 sitesstarted 2026Weill Medical College of Cornell University
Check eligibility and contact details →
Recruiting nowPhase 3510 planned
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Locations: The Bronx, New York
Ages: 12 Years1 sitestarted 2026Nektar Therapeutics
Check eligibility and contact details →
Recruiting nowPhase 440 planned
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Locations: Sacramento, California
Ages: 12 Years1 sitestarted 2026Integrative Skin Science and Research
Check eligibility and contact details →

This is the same registry search as the trial finder, already set to Eczema. Change the country, or search a different condition, at any time.

Read the Eczema guide See every condition the finder covers

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.